IP Library › Granted Patent US 7,371,827
Granted Patent B2
US 7,371,827 · App. 10/127,822 · Granted May 13, 2008

Antibodies against the PRO1126 polypeptide

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,371,827
App. No.
10/127,822
Granted
May 13, 2008
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (5)

1. An isolated antibody that specifically binds to the polypeptide of SEQ ID NO:468.

2. The antibody of claim 1 which is a monoclonal antibody.

3. The antibody of claim 1 which is a humanized antibody.

4. The antibody of claim 1 which is labeled.

5. An isolated antibody fragment that specifically binds to the polypeptide of SEQ ID NO:468.

Continuity (6)
Continuation 1002807200 · Dec 19, 2001
Continuation PCTUS003267800 · Dec 1, 2000
Continuation In Part PCTUS992831300 · Nov 30, 1999
Continuation In Part 0938013700
Provisional Application 6008953200 · Jun 17, 1998
Related Publication 20030087351A1 · May 8, 2003